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In vertebrates, activation of innate immunity is an
early response to injury, implicating it in the regener-
ative process. However, the mechanisms by which
innate signals might regulate stem cell functionality
are unknown. Here, we demonstrate that type 2
innate immunity is required for regeneration of skel-
etal muscle after injury. Muscle damage results in
rapid recruitment of eosinophils, which secrete IL-4
to activate the regenerative actions of muscle resi-
dent fibro/adipocyte progenitors (FAPs). In FAPs,
IL-4/IL-13 signaling serves as a key switch to control
their fate and functions. Activation of IL-4/IL-13
signaling promotes proliferation of FAPs to support
myogenesis while inhibiting their differentiation into
adipocytes. Surprisingly, type 2 cytokine signaling
is also required in FAPs, but not in myeloid cells,
for rapid clearance of necrotic debris, a process
that is necessary for timely and complete regenera-
tion of tissues.INTRODUCTION
The regenerative response of skeletal muscle to injury is depen-
dent on the quiescent population of skeletal muscle stem cells,
termed the satellite cells, which reside beneath the basal lamina
of each myofiber (Brack and Rando, 2012; Wang and Rudnicki,
2012). Upon injury, these quiescent satellite cells become acti-
vated and undergo proliferation, giving rise to myogenic pro-376 Cell 153, 376–388, April 11, 2013 ª2013 Elsevier Inc.genitors (MPs) that ultimately differentiate into mature myofib-
ers. In this context of injury and repair, a number of factors
have been identified that promote proliferation and differentia-
tion of MPs (Kuang et al., 2008). For instance, autocrine Notch
signaling regulates the activation and proliferation of satellite
cells (Bjornson et al., 2012; Conboy et al., 2003; Conboy and
Rando, 2002; Mourikis et al., 2012), whereas paracrine actions
of interleukin (IL)-6 and insulin-like growth factors (IGFs) have
been implicated in the differentiation of MPs into mature myo-
tubes (Bodine et al., 2001; Rommel et al., 2001; Serrano et al.,
2008).
In addition to satellite cells, recent studies have identified an
important role for fibro/adipogenic progenitors (FAPs) in muscle
regeneration and its fatty degeneration (Joe et al., 2010; Uezumi
et al., 2010). FAPs, which do not arise from themyogenic lineage,
are bipotential cells capable of giving rise to fibroblasts and
adipocytes. The close association of FAPs with regenerating
muscle fibers, along with their expression of factors that influ-
ence myogenic differentiation, such as IL-6 and IGF-1, suggests
that these stromal cells may play a supportive role in myogenic
differentiation (Joe et al., 2010). However, reflecting their adipo-
genic potential, FAPs can also give rise to ectopic adipocytes
that accumulate in degenerating muscles (Uezumi et al., 2010).
Based on these findings, it has been postulated that factors
that modulate the proliferation or differentiation of FAPs could
potentially influence the muscle’s regenerative response to
injury; however, none have been identified to date.
Muscle injury results in rapid activation of the innate immune
system, which exerts pleiotropic effects on regenerating muscle
(Brunelli and Rovere-Querini, 2008; Tidball and Villalta, 2010).
Within minutes of injury, neutrophils infiltrate injured skeletal
muscle and release tissue-damaging reactive molecules, which
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Figure 1. IL-4/IL-13 Signaling Is Required for
Muscle Regeneration
(A and D) TA muscles of WT, IL-4/IL-13/ (A), and
IL-4Ra/ (D) mice 8 days after injury by CTX.
(B and E) Representative TA muscle sections of
WT, Il4/Il13/ (B), and Il4ra/ (E) were stained
with hematoxylin and eosin 8 days after injury; n = 6
per genotype (magnification, 2003).
(C and F) Fluorescent microscopy of WT, Il4/Il13/
(C), and Il4ra/ (F) TA muscles 8 days after injury
(magnification, 2003). Desmin, green; and DAPI,
blue.
See also Table S1.exacerbate muscle damage (Tidball, 1995). This initial burst of
collateral damage caused by the innate immune system is fol-
lowed by a wave of reparative macrophages. For instance, it
has been proposed that classically activated (M1) macrophages
infiltrate early to facilitate the clearance of necrotic debris,
whereas alternatively activated (M2) macrophages infiltrate later
to assist with muscle growth (Arnold et al., 2007). In support of
this idea, impairment in transcriptional programming of M2
macrophages, as in mice with reduced expression of C/EBPb,
results in smaller regenerated myofibers (Ruffell et al., 2009),
potentially reflecting the reduced secretion of myogenic growth
factor IGF-1 by these cells (Wynes and Riches, 2003). Although
these studies demonstrate a facilitative role of innate immune
cells in muscle regrowth after injury, a direct molecular link
between the innate immune system and muscle progenitor
biology remains to be established.Cell 153, 376–In a number of species, tissue regenera-
tion is associated with the presence of the
molecular signature for type 2 innate
immune response, such as alternatively
activated (M2) macrophages and eosino-
phils (Allen and Wynn, 2011; Palm et al.,
2012). This observation led us to postulate
that signals—such as IL-4 and IL-13—that
orchestrate type 2 innate immune re-
sponses might be good candidates for
mediating the crosstalk between the im-
mune system and skeletal muscle stem
cells. Here, we report that muscle injury
leads to the recruitment of IL-4 secreting
eosinophils, which form an adaptive niche
for proliferating stem cells in regenerating
muscles. Loss of IL-4/IL-13 signaling or
genetic absence of eosinophils severely
compromises the ability of injuredmuscles
to regenerate. Unexpectedly, we find that
the regenerative effects of IL-4/IL-13 are
not mediated by its signaling in myeloid
cells but rather in FAPs. In FAPs, IL-4
acts as a molecular switch to control their
fate between fibroblasts and adipocytes
and to promote the clearance of necrotic
debris. Consequently, global or cell-
specific loss of IL-4/IL-13 signaling inFAPs severely impairs their functionality, resulting in persistence
of necrotic debris and impairment in muscle regeneration.
RESULTS
IL-4/IL-13 Signaling Is Required for Muscle
Regeneration
To investigate the functions of IL-4/IL-13 in muscle regeneration,
we used cardiotoxin (CTX) to acutely injure the tibialis anterior
(TA) muscles of mice. CTX administration induces local muscle
necrosis, which is rapidly followed by recruitment of inflamma-
tory cells, clearance of cellular debris, and regeneration of
injured muscle (Uezumi et al., 2010). To evaluate the overall effi-
cacy of the regenerative response, we gave mice an intraperito-
neal injection of Evans blue dye, which accumulates in damaged
muscle fibers (Figure 1). Wild-type (WT) mice exhibited a robust388, April 11, 2013 ª2013 Elsevier Inc. 377
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Figure 2. IL-4-Expressing Eosinophils Are
Required for Muscle Regeneration after
Injury
(A) IL-4-expressing cells infiltrate injured muscles.
One or two days after injury with CTX, TA muscles
from 4get mice were stained for GFP (magnifica-
tion, 4003).
(B) Flow cytometric gating strategy for identifica-
tion of IL-4-expressing cells in injured muscles.
Eosinophils were defined as being CD11b+ and
Siglec F+, whereas mast cells were CD117+ and
FcεRI+.
(C) IL-4-expressing cells in 4get and 4get-
DdblGATA mice 36 hr after injury with CTX.
(D) Eosinophils in 4get and 4get-DdblGATA mice
36 hr after muscle injury.
(E) TA muscles from WT and DdblGATA mice
8 days after injury.
(F) Hematoxylin and eosin staining of repre-
sentative muscle sections taken from WT and
4get-DdblGATA mice 8 days after injury; n = 6 per
genotype (magnification, 2003).
(G) Immunostaining of TA muscle sections of WT
and DdblGATA mice 8 days after CTX injury
(magnification, 2003). Desmin, green; and DAPI,
blue.
See also Figure S1.regenerative response, resulting in the restoration of intact, re-
generating fibers, as evidenced by the absence of Evans blue
staining of TA muscles (Figure 1A). In striking contrast, Evans
blue dye uptake was markedly higher in TA muscles of Il4/
Il13/ mice, which is indicative of a failure of the regenerative
response to restore mature, intact myofibers (Figure 1A). In
agreement with this interpretation, histological examination re-
vealed that TA muscles of WT mice contained centrally nucle-
ated regenerative myofibers, which were largely absent from
those of Il4/Il13/ mice (Figure 1B). Instead, cellular debris
and inflammatory infiltrate persisted in the injured TA muscles
of Il4/Il13/ mice (Figure 1B). Moreover, immunostaining for
desmin, a marker of mature myofibers, showed a near complete
absence of regenerated muscle fibers in Il4/Il13/ mice (Fig-
ure 1C). This impairment in muscle regeneration did not result
from altered trafficking of immune cells into injured muscles of
Il4/Il13/ mice (Table S1 available online).
Two distinct receptors (IL-4Ra/gc and IL-4Ra/IL-13Ra1)
transduce the biologic effects of IL-4 and IL-13 in cells (Kelly-
Welch et al., 2003). Using Il4ra/ mice, we next investigated378 Cell 153, 376–388, April 11, 2013 ª2013 Elsevier Inc.whether the canonical IL-4/IL-13 sig-
naling pathwaysmediate the regenerative
responses in injured muscles. Both at a
gross and microscopic level, Il4ra/
mice exhibited similar defects in skeletal
muscle regeneration as Il4/Il13/ mice
(Figures 1D and 1E). Moreover, immuno-
fluorescence staining for desmin demon-
strated an absence of centrally nucleated
fibers in the regenerating TA muscles of
Il4ra/ mice (Figure 1F). These findings
provide strong genetic evidence that the IL-4/IL-13 immune sig-
nals play a central role in skeletal muscle regeneration and raise
three important questions: (1) what is the cellular source of IL-4
during muscle regeneration, (2) what cells respond to IL-4/
IL-13 in regenerating muscle, and (3) how do IL-4/IL-13 promote
muscle regeneration?
Eosinophils Are Required for Muscle Regeneration
To prospectively identify the cellular source of IL-4 in regenerat-
ingmuscles, we utilized 4get reporter mice, which express green
fluorescent protein (GFP) from the 30 UTR of the endogenous Il4
gene (Mohrs et al., 2001). GFP+ cells, which were readily
identified throughout the time course of muscle regeneration
(Figure 2A and Figure S1A), were primarily of hematopoietic
origin, as they coexpressed CD45 (Figure S1B). To characterize
the identity of these IL-4-expressing cells, we analyzed the
expression of markers for eosinophils (Siglec F+CD11b+), baso-
phils (FceRI+CD117), mast cells (FceRI+CD117+), and Th2 cells
(CD3+CD4+) in the GFP+ population that infiltrated injured
muscles of 4get mice. Notably, 85%–90% of GFP+ cells were
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B Figure 3. IL-4/IL-13 Signaling in Myeloid
Cells Is Dispensable for Muscle Regenera-
tion
(A) Expression of IL-4Ra in MPs, FAPs, and
myeloid cells (CD11b+).
(B) Time course of IL-4Ra expression in FAPs,
MPs, and CD45+ hematopoietic cells.
(C and D) Expression of arginase 1 (Arg1) and
iNOS (Nos2) mRNAs in regenerating TAmuscles of
WT mice; n = 4–6 per time point.
(E) Fluorescent microscopy for Arg1 (red), Nos2
(green), and DAPI (blue) 2 days after muscle injury
of WT mice (magnification, 4003).
(F) GFP staining of TA muscles of YARGmice after
injury (magnification, 2003).
(G) TA muscles 8 days after injury in Il4raf/f and
Il4raf/fLysMCre mice.
(H) Representative day 8 muscle sections
from Il4raf/f and Il4raf/fLysMCre mice stained with
hematoxylin and eosin; n = 6 per genotype.
(I) Fluorescent microscopy of Il4raf/f and Il4raf/f
LysMCre TA muscles 8 days after injury. Desmin in
green and DAPI in blue.
Error bars represent SEM. See also Figure S2.eosinophils, whereas the remainder were mast cells (Figure 2B).
Consistent with this, expression of chemokines and cytokines
involved in chemotaxis of eosinophils was induced in CTX-
injured muscles (Figure S1C).
Because eosinophilswere thedominant cell type secreting IL-4
in injured muscles, we next investigated their involvement in
muscle’s regenerative response using eosinophil-deficient
DdblGATA mice (Yu et al., 2002). Flow cytometric analyses of
4get-DdblGATA mice revealed a near complete absence (>93%
reduction) of infiltrating eosinophils in injured TA muscles (Fig-
ure 2C). Moreover, the absence of eosinophils reduced the total
number ofGFP+ cells by75% (Figure S1D), decreased the num-
ber of IL-4-expressing eosinophils by 30-fold (Figure 2D), and
completely abolished the expression of IL-4 in mononuclear cells
derived from DdblGATA mice (Figure S1E). Consequently, 4get-
DdblGATAmice were unable to regenerate their injuredmuscles,
as assessed by Evans blue staining of their TA muscles (Fig-Cell 153, 376–3ure 2E). Paralleling the changes in the
gross phenotype, hematoxylin and eosin
staining of tissue sections revealed a
paucity of centrally nucleated regenerat-
ing myofibers (Figure 2F), a finding that
was confirmed by immunostaining for
desmin (Figure 2G). These results suggest
that eosinophil-derived factors, such
as IL-4, are essential for orchestrating
skeletal muscle regeneration.
Myeloid Cells and FAPs Exhibit
Competence for IL-4/IL-13
Signaling
To elucidate the target cells that respond
to IL-4/IL-13 in injured muscles, we pro-
filed the expression of IL-4Ra on variouscell types that participate in the repair of damaged skeletal mus-
cle. For these studies, we utilized flow cytometry and established
gating strategies to identify myogenic progenitors (MPs), FAPs,
and myeloid cells (Figure S2A) and then evaluated the expres-
sion of IL-4Ra on each of these populations. Figure 3A shows
that IL-4Ra is specifically expressed on WT FAPs and myeloid
cells and is largely absent from the cell surface of MPs. Because
stimulation with IL-4/IL-13 induces the expression of IL-4Ra
(Kelly-Welch et al., 2003), the relative change in its expression
serves as a good indicator of target cell responsiveness to these
cytokines. Indeed, temporal profiling revealed that IL-4Ra
expression was rapidly induced on the surface of FAPs and
CD45+ cells, but not MPs, after injury (Figure 3B). This observed
increase in IL-4Ra expression coincided with the presence of IL-
4-expressing eosinophils in injured muscle (Figure 2A), implying
that the primary regenerative actions of these cytokinesmight be
restricted to this early time frame after injury.88, April 11, 2013 ª2013 Elsevier Inc. 379
IL-4/IL-13 Signaling in Myeloid Cells Is Dispensable for
Muscle Regeneration
An early event that occurs aftermuscle injury is the recruitment of
macrophages, which exert pleiotropic effects on muscle regen-
eration (Tidball and Villalta, 2010). Classically activated (also
referred to as M1) macrophages infiltrate damaged muscle
within the first 2 days and have been implicated in the clearance
of cellular debris and stimulation of myogenesis. In contrast,
alternatively activated (also referred to as M2) macrophages,
whose numbers increase during later stages of muscle regener-
ation (days 4–10), are implicated in the promotion of muscle
growth via secretion of paracrine factors. Because IL-4, the
dominant regulator of alternative macrophage activation (Marti-
nez et al., 2009; Odegaard and Chawla, 2011), is expressed
during the early phase of muscle injury (Figures 2A and S2B),
we postulated that the observed defects in muscle regenera-
tion might stem from impairment in alternative macrophage
activation.
First, we examined the time course of macrophage recruit-
ment into injured muscle. In contrast to the previous report
(Arnold et al., 2007), quantitative RT-PCR analysis of whole TA
muscles revealed that expression of messenger RNAs (mRNAs)
encoding classical (Nos2, Il6, and Tnfa) and alternative activation
(Arg1 and Ym1) genes was rapidly induced during the first two
days of muscle injury (Figures 3C, 3D, and S2C–S2F). To exclude
the possibility that markers of classical and alternative activation
might be concurrently expressed in the same cells, we analyzed
expression of arginase 1 (Arg1) and inducible nitric oxide syn-
thase (Nos2) by immunostaining. Arg1 expression was primarily
restricted to cells that express the macrophage marker Cd68
(Figure S2G). Furthermore, alternative (Arg1) and classical
(Nos2) activation markers were expressed in distinct macro-
phages (Figure 3E), which is indicative of concurrent infiltration
of damaged muscle by both types of macrophages. This obser-
vationwas independently verified using YARGmice (Reese et al.,
2007), which have a fluorescent reporter introduced into theArg1
gene (Figure 3F). In aggregate, these data demonstrate that
muscle injury leads to rapid recruitment of both alternatively
(M2) and classically (M1) activated macrophages.
We tested whether alternatively activated macrophages are
required for muscle regeneration using control (Il4raf/f) and
myeloid-cell-specific knockouts of the IL-4Ra (Il4raf/fLysMCre).
To our surprise, unlike the Il4/Il13/ and IL-4Ra/ mice,
myeloid cell deletion of Il4ra (Figure S2H) did not result in a
strong defect in skeletal muscle regeneration (Figures 3G–3I).
These findings suggest that myeloid cells are not the primary
targets for the regenerative effects of IL-4/IL-13 during muscle
injury.
IL-4/IL-13 Stimulate Proliferation of FAPs In Vivo
FAPs, which are present in healthy muscle, undergo rapid
proliferation after muscle injury to support myogenic differentia-
tion (Joe et al., 2010). Because IL-4Ra is highly expressed in
FAPs (Figure 3B), we hypothesized that IL-4/IL-13might regulate
proliferation or differentiation of FAPs. To investigate this postu-
late, we utilized flow cytometry to identify FAPs and MPs on day
1 after injury and followed their proliferation using 5-bromodeox-
yuridine (BrdU) incorporation. Strikingly, absence of IL-4/IL-13 or380 Cell 153, 376–388, April 11, 2013 ª2013 Elsevier Inc.IL-4Ra decreased BrdU incorporation in FAPs by60% (Figures
4A, 4B, and S3A) and reduced the FAP content of regenerating
muscles on day 3 by40%–45% (Figure S3C). Albeit to a slightly
lower degree, BrdU incorporation was also reduced in FAPs of
DdblGATAmice (40%), which lack IL-4-expressing eosinophils
in their regenerating muscles (Figure 4C).
Muscle injury also leads to proliferation of MPs, which are
required for myogenesis (Brack and Rando, 2012; Wang and
Rudnicki, 2012). We tested whether absence of eosinophils or
loss of IL-4/IL-13 signaling decreased the proliferation of MPs.
In contrast to FAPs, the rate of BrdU incorporation in MPs was
not significantly different among WT, Il4/Il13/, and Il4ra/
mice (Figures 4D, 4E, and S3B). However, we did observe a
modest decrease in the proliferation rate of MPs in eosinophil-
deficient DdblGATA mice (Figure 4F). These data are consistent
with the observation that IL-4Ra is not expressed on MPs at any
stage of muscle regeneration (Figure 3B), thereby suggesting
that FAPs are likely the primary target of IL-4/IL-13 signaling in
regenerating muscle. Congruent with this idea, we failed to
detect significant differences in the proliferation rates of FAPs
or MPs in Il4raf/f and Il4raf/fLysMCremice (Figures S3D and S3E).
Previous studies have implicated IL-4 signaling in myoblast
fusion and muscle fiber growth (Horsley et al., 2003), prompting
us to examine the role of IL-4Ra in regenerating muscle fibers.
Western blot analysis of purified FAPs and MPs revealed robust
expression of IL-4Ra and PDGFRa in FAPs, but not in MPs (Fig-
ure S3F). In contrast to MPs, IL-4Ra protein was detectable in
MP-derived myotubes, which displayed fused morphology and
higher expression of desmin (Figure S3F). This observation
prompted us to generate mice (designated Il4raf/fPax7CreERT2)
in which IL-4Ra could be deleted in Pax7+ satellite cells in a
tamoxifen-inducible manner (Lepper et al., 2009). As quantified
by quantitative PCR (qPCR), administration of tamoxifen for
5 days induced >90% recombination at the Il4ra locus (Fig-
ure S3G). Because Pax7+ satellite cells give rise to all regenerat-
ing myofibers (Lepper et al., 2009), we investigated the require-
ment for IL-4Ra in satellite cell-derived myofiber regrowth.
Notably, deletion of IL-4Ra in satellite cells did not impair the
muscle’s regenerative response to injury by CTX, as assessed
by gross and microscopic histology (Figures 4G and 4H). In
agreement with these observations, we failed to detect expres-
sion of IL-4Ra in regenerating myofibers in vivo (Figure S3H).
IL-4 Signaling via IL-4Ra and STAT6 Stimulates
Proliferation of FAPs In Vitro
We purified FAPs from CTX-injured muscles (day 1) using the
Miltenyi MACS purification system in order to study the signaling
pathways activated by IL-4 in these cells. This method of nega-
tive selection allowed us to isolate FAPs that wereR98% pure;
i.e., CD31CD45a7-integrinSCA-1+ (Figure S4A). Similar to
what was observed in vivo, stimulation of WT FAPs with IL-4
induced cell proliferation, as evinced by the increase in cell
number (2-fold at 48 hr and 4-fold at 72 hr, Figure S4B). To
elucidate the pathways that mediate the mitogenic effects of
IL-4, we investigated the downstream signaling pathways that
are activated by IL-4 in FAPs. Stimulation with IL-4 activated
three major signaling pathways in FAPs: (1) signal transducer
of transcription 6 (STAT6), (2) the protein kinase Akt, and (weakly)
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Figure 4. IL-4/IL-13 Signaling Controls Pro-
liferation of FAPs, but Not Satellite Cells,
during Muscle Regeneration
(A–C) Quantification of BrdU incorporation in FAPs
of WT, Il4/Il13/, and DdblGATA mice 24 hr after
muscle injury; n = 4 per genotype.
(D–F) Quantification of BrdU incorporation in MPs
of WT, Il4/Il13/, and DdblGATA mice 24 hr after
muscle injury; n = 4 per genotype.
(G and H) Signaling via IL-4Ra in satellite cells is
dispensable for muscle regrowth after injury. (G)
Representative day 8 muscle sections from Il4raf/f
and Il4raf/fPax7CreERT2 mice stained with hema-
toxylin and eosin; n = 6 per genotype (magnifica-
tion, 2003). (H) Gross appearance of Il4raf/f and
Il4raf/fPax7CreERT2 TA muscles 8 days after injury
with CTX.
Error bars represent SEM. See also Figure S3.(3) the extracellular signal-regulated protein kinases (ERKs) (Fig-
ure 5A). As expected, inhibition of PI3K by LY294002 prevented
serine phosphorylation of Akt, whereas the MEK1 inhibitor
PD98059 potently inhibited phosphorylation of ERK1/2 (Fig-
ure S4C). Moreover, consistent with the direct tyrosine phos-
phorylation of STAT6 proteins by Janus kinases (Shuai and Liu,
2003), treatment with PI3K or MEK1 inhibitors did not alter the
phosphorylation status of STAT6 (Figure S4C). Lastly, activation
of these three signaling pathways in FAPs showed an absolute
dependence on IL-4Ra, as their phosphorylation and activation
were abolished in Il4ra/ FAPs (Figure 5A).
We next examined which pathway was required for IL-4-
induced proliferation of FAPs. Consistent with the loss of IL-4
signaling, IL-4 failed to increase cell number or BrdU incorpora-
tion in Il4ra/ FAPs (Figures 5B and 5C). Likewise, Stat6/
FAPs failed to proliferate in response to IL-4, as quantified byCell 153, 376–3the change in cell number and the rate
of BrdU incorporation (Figures 5B and
5D). In contrast, treatment of FAPs with
PI3K or MEK1 inhibitors did not signifi-
cantly alter the stimulatory effects of
IL-4 on BrdU incorporation (Figure S4D).
Together, these findings suggest that
STAT6 predominantly mediates the mito-
genic effects of IL-4 in FAPs.
In order to understand how IL-4/STAT6
transcriptional axis regulates proliferation
of FAPs, we performed microarray ana-
lyses from WT and Il4ra/ FAPs stimu-
lated with IL-4 for 24 hr. Pathway analysis
of differentially expressed genes revealed
that gene ontology (GO) terms associated
with DNA replication, cell cycle, and
mitosis were highly enriched in the upre-
gulated gene set, whereas those associ-
ated with triglyceride metabolism and
lipid biogenesis were significantly down-
regulated in WT FAPs treated with IL-4
(Tables S2, S3, and S4). qRT-PCR ana-lyses further verified that IL-4 induced the expression of a num-
ber of cell cycle genes, including Cdc20, Ccnd1, Cdk1, Cdc7,
Cdca3, and Cenpa, in WT, but not in Il4ra/ or Stat6/ FAPs
(Figure 5E). In aggregate, these data demonstrate that mitogenic
actions of IL-4 enhance the proliferation of FAPs by promoting
their entry and progression through the cell cycle.
In coculture systems, FAPs can promote differentiation of MPs
into myofibers (Joe et al., 2010). Therefore, we tested whether
stimulation of FAPs with IL-4 might enhance their capacity to
support myogenic differentiation. WT MPs were cultured with
FAPs-conditioned medium, and myogenic gene expression
was measured 5 days later. Treatment of MPs with conditioned
medium taken from IL-4 stimulated WT FAPS, but not from
Il4ra/ FAPs, enhanced myogenic differentiation, as evidenced
by increased expression of myogenic transcription factors and
structural proteins (Figures 5G and S4E). Because conditioned88, April 11, 2013 ª2013 Elsevier Inc. 381
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Figure 5. IL-4 Promotes Proliferation of FAPs In Vitro
(A) Activation of signaling pathways by IL-4 in WT, Il4ra/, and Stat6/ FAPs.
(B) Quantification of cell number after stimulation of WT, Il4ra/, and Stat6/ FAPs with vehicle or IL-4 for 48 hr; n = 4 per genotype and time point. For each
genotype, cell number is normalized to its vehicle control.
(C and D) BrdU incorporation in WT, Il4ra/, and Stat6/ FAPs after stimulation vehicle or IL-4 (10 nM) for 24 hr.
(E) Heatmap of differentially expressed genes in WT and Il4ra/ FAPs treated with vehicle or IL-4 for 24 hr; red, induced; blue, repressed. GO terms associated
with DNA replication, cell cycle, andmitosis are enriched in the upregulated gene set, whereas those associatedwith triglyceridemetabolism and lipid biogenesis
are enriched in the downregulated gene set.
(legend continued on next page)
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Figure 6. IL-4 Inhibits Adipogenic Differenti-
ation of FAPs In Vitro and In Vivo
(A) qRT-PCR analysis of adipogenic genes in WT
FAPs cultured for 7 days in the presence or
absence of IL-4; n = 3 per treatment.
(B) Oil red O staining of WT and Stat6/ FAPs
differentiated with insulin in the absence or pres-
ence of IL-4 (magnification, 2903).
(C) Immunoblot analysis for adipogenic proteins in
WT FAPs treated with insulin or insulin plus IL-4.
(D) Oil red O staining of regenerating TA muscles
was performed on day 5 (magnification, 2003).
(E) TA muscles were analyzed on day 8 after
glycerol injection by oil red O staining. After initi-
ating glycerol-inducedmuscle damage, mice were
injectedwith vehicle or IL-4 complex on days 1 and
4; n = 4–6 per treatment. Representative sections
stained for oil red O are shown.
(F) Hematoxylin and eosin staining of TA muscle
sections on day 8 after glycerol-induced injury
(magnification, 2003).
(G) qRT-PCR analysis of adipocyte-specific genes
in uninjured and glycerol-injured TA muscles; n =
4–6 per treatment.
Error bars represent SEM. See also Figure S5.medium taken from IL-4-stimulated FAPs did not stimulate pro-
liferation of MPs in single myofiber preparations (Figure S4F), it
suggests that factors derived from FAPs likely work in trans to
enhance terminal differentiation of myoblasts.
IL-4 Inhibits Adipogenic Differentiation of FAPs
FAPs isolated from injured muscle can be induced to differen-
tiate into mature adipocytes in culture (Joe et al., 2010; Uezumi
et al., 2010). Because a large number of genes involved in triglyc-
eride synthesis and adipogenesis were repressed by IL-4 in
FAPs (Tables S2 and S4), we tested whether IL-4 could prevent
differentiation of FAPs into adipocytes. As shown in Figure S5A,(F) qRT-PCR analysis of cell cycle genes in WT, Il4ra/, and Stat6/ FAPs after stimulation with vehicle or
(G) Expression of myogenic genes in WT MPs cultured with FAPs conditioned media. FAPs were stimulated
conditioned media; n = 3 per treatment.
Error bars represent SEM. See also Figure S4 and Tables S2, S3, and S4.
Cell 153, 376–3FAPs cultured in growth medium sponta-
neously differentiated into lipid-laden ad-
ipocytes, a process that was completely
inhibited by IL-4. Moreover, qRT-PCR
analysis revealed that IL-4 suppressed
the expression of a number of genes
that are normally induced during adipo-
genesis (Rosen et al., 2000), including
PPARg, Lep, Fabp4, Acaca, Cd36, and
Dgat2 (Figure 6A).
Because IL-4 suppressed spontaneous
differentiation of FAPs into adipocytes,
we testedwhether it could also inhibit adi-
pogenic conversion of FAPs by insulin. As
assessed by microscopy and staining for
oil red O, treatment with IL-4 potentlysuppressed insulin-induced differentiation of FAPs into adipo-
cytes (Figures 6B and S5B). This was further affirmed by expres-
sion analysis, which revealed a strong repressive effect of IL-4 on
expression of adipogenic genes inWT FAPs (Figure S5C). Impor-
tantly, signaling via IL-4Ra and STAT6 was required because no
significant inhibition of adipogenesis was observed in Il4ra/ or
Stat6/ FAPs (Figures 6B and S5C). Congruent with these
observations, treatment with IL-4 repressed expression of adi-
pogenic proteins, such as PPARg, Acc1, and HSL, by insulin
(Figure 6C).
Because IL-4 signaling inhibits adipogenic differentiation of
FAPs, we tested whether genetic disruption of IL-4/IL-13IL-4 for 24 hr; n = 4 per genotype and treatment.
with vehicle or IL-4 for 72 hr prior to collection of
88, April 11, 2013 ª2013 Elsevier Inc. 383
AD
F
I
J
K
G
H
E
B C
Figure 7. FAPs Phagocytize Cellular Debris in Regenerating Muscle
(A) FAPs phagocytize necrotic cells in vitro. FAPs isolated from regeneratingmuscles were fedCFSE-labeled thymocytes for 1 hr; n = 3. LTs, live thymocytes; NTs,
necrotic thymocytes; ATs, apoptotic thymocytes; OTs, opsonized thymocytes.
(B) Confocal microscopy of WT FAPs phagocytizing necrotic thymocytes (magnification, 1,2003). PDGFRa staining (red) identifies FAPs, whereas CFSE (green)
represents necrotic thymocytes. Blue is DAPI.
(legend continued on next page)
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signaling results in fatty infiltration of regenerating muscle. In
agreement with published reports (Uezumi et al., 2010), we failed
to detect a significant number of adipocytes in regenerating
muscles of WT mice (Figure 6D). In contrast, clusters of oil-
red-O-positive adipocytes were readily detected in regenerating
muscles of Il4/Il13/ and Stat6/ mice (Figure 6D).
IL-4 Prevents Fatty Degeneration of Muscle
FAPs are bipotential cells capable of facilitating skeletal muscle
regeneration or contributing to its fatty degeneration (Joe et al.,
2010; Uezumi et al., 2010). Because IL-4 serves as a molecular
switch for controlling the fate of FAPs in regenerating muscle,
we postulated that administration of IL-4 might prevent fatty
degeneration of injured skeletal muscle. To test this hypothesis,
we injected glycerol into the TA muscles of WT mice to induce
fatty degeneration of skeletal muscle (Arsic et al., 2004). As
reported, glycerol-injected TA muscles were infiltrated by oil-
red-O-positive cells (Uezumi et al., 2010), which stained positive
for the adipocyte lipid droplet protein perilipin (Figures 6E and
S5D). In contrast, fatty infiltration and perilipin staining was
dramatically reduced in TA muscles of all mice (n = 6) that
received intraperitoneal injections of IL-4 (Figures 6E, 6F, and
S5D). Paralleling the decrease in fatty infiltration, expression of
adipocyte-specific genes, such as leptin (Lep) and adiponectin
(Adipoq), was reduced by 65% in TA muscles of mice treated
with IL-4 (Figure 6G).
FAPs Clear Necrotic Debris in Regenerating Muscle
Although FAPs can support myogenic differentiation, this obser-
vation is unlikely to explain the histologic defects in muscle
regeneration observed in mice lacking type 2 innate immunity,
including DdblGATA, Il4/Il13/, and Il4ra/ mice. In these
animals, a common histologic finding is the impaired clearance
of necrotic muscle fibers, prompting us to examine whether
FAPs might participate in the phagocytosis of necrotic debris.
To investigate this idea, we purified FAPs from injured muscles
of WT mice on day 3 and fed them CFSE-labeled live, necrotic,
apoptotic, or opsonized thymocytes (Mukundan et al., 2009).
Remarkably, FAPs were very efficient at phagocytizing necrotic
thymocytes, as assessed by the percentage of FAPs that were
positive for CFSE and their mean fluorescence intensity (Figures
7A, S6A, and S6B). This response was specific for necrotic
thymocytes because live, apoptotic, and opsonized thymocytes
were not phagocytized at any appreciable level by FAPs (Figures
7A, S6A, and S6B). Moreover, confocal microscopy revealed
that FAPs, which uniformly express PDGFRa (Uezumi et al.,
2010), had indeed engulfed the necrotic thymocytes (Figures
7B and S6C).(C and D) FAPs are efficient at phagocytizing necrotic debris in vivo. (C) Three
necrotic thymocytes, and phagocytosis was enumerated 1 hr later. Data are plo
microscopy of FAPs in regenerating muscle (magnification, 6003). Red, PDGFR
(E and F) Representative images of Il4raf/f and Il4raf/fPdgfraCre TA muscles 8 day
muscles (magnification, 1003). (F) Hematoxylin and eosin staining of representa
(G and H) Quantification of CFSE+ FAPs in WT, DdblGATA, and Il4ra/ mice; n
(I and J) IL-4 promotes clearance of necrotic debris in regenerating muscle. Repre
debris as visualized by Alizarin red S stain (magnification, 403) (J); n = 5 per trea
(K) Model for functions of type 2 immunity in regenerating muscles.
Error bars represent SEM. See also Figures S6 and S7.We next asked whether FAPs were capable of phagocytizing
necrotic cellular debris in the context of injured muscle, a setting
in which macrophages, the professional phagocytes implicated
in clearance of necrotic debris (Arnold et al., 2007), are abun-
dantly present. For these experiments, CFSE-labeled necrotic
thymocytes were injected into injured TA muscles, and uptake
of necrotic debris by various cellular populations was quantified
1 hr later by flow cytometry. Surprisingly, compared to macro-
phages, FAPs were 4-fold more efficient at phagocytizing
necrotic thymocytes (Figures 7C and S6D–S6H). In contrast,
no significant uptake of necrotic thymocytes was observed in
MPs or CD31+ endothelial cells. Consistent with this observa-
tion, PDGFRa+ FAPs were observed circumscribing necrotic
muscle fibers, which can be distinguished by nonspecific depo-
sition of IgG (Figure 7D). Together, these data demonstrate that
FAPs are capable of phagocytizing necrotic debris in injured
muscle, leading us to postulate that they might be the primary
cell type responsible for clearance of necrotic fibers in injured
muscle.
To test this hypothesis, we examined whether PDGFRa is
selectively expressed in FAPs of injured muscle. Analysis of
PdgfraEGFP mice, which harbor a knockin of H2B-eGFP fusion
gene into the endogenous Pdgfra locus (Hamilton et al., 2003),
showed that GFP was exclusively expressed in FAPs of regener-
ating muscles (Figure S7A). Based on these observations, we
crossed Il4raf/f with PdgfraCre mice to selectively delete Il-4ra
in FAPs (designated Il4raf/fPdgfraCre) (Roesch et al., 2008).
Flow cytometric analysis of mononuclear cells isolated from re-
generating muscles confirmed the absence of IL-4Ra protein in
FAPs, but not in CD45+ or CD31+ cells (Figure S7B). Notably,
after CTX-mediated injury, skeletal muscles of Il4raf/fPdgfraCre
mice recapitulated many of the histologic features observed in
mice lacking type 2 immunity, including persistence of necrotic
debris, larger areas of injury, and decreased formation of regen-
erative muscle fibers (Figures 7E and 7F). In aggregate, these
findings suggest that regenerative actions of type 2 innate cyto-
kines IL-4 and IL-13 are directly mediated via their actions
in FAPs.
Finally, we examined the role of type 2 innate signals in clear-
ance of necrotic debris in injured muscle. Three days after
muscle injury with CTX, mice were injected with CFSE-labeled
necrotic thymocytes, and the presence of CFSE in FAPs was
assessed 90 min later. This time point was chosen because
CFSE signal in WT FAPs peaked at 60 min, followed by a
decline over the next hour (Figure S7C). In mice impaired in
type 2 innate signaling, such as DdblGATA and Il4ra/ mice,
a higher percentage of FAPs were CFSE+, suggesting delayed
clearance of necrotic debris in these cells (Figures 7G, 7H, anddays after CTX-induced injury, TA muscles were injected with CFSE-labeled
tted as percent uptake in the indicated cellular population; n = 3. (D) Confocal
a; green, IgG.
s after injury CTX; n = 4–5 per genotype. (E) Evans blue staining of CTX-injured
tive section (magnification, 2003).
= 6–8 per genotype.
sentative images of IgG deposition (magnification, 5803) (I) or calcified necrotic
tment.
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S7D). Consistent with this notion, administration of IL-4 into
Il4/Il13/ was sufficient to enhance clearance of necrotic
muscle fibers, as assessed by deposition of IgG in the nec-
rotic myofibers or staining for calcified myofibers (Figures 7I
and 7J).
DISCUSSION
Although activation of the immune system is one of the earliest
events that occur during tissue regeneration (Stoick-Cooper
et al., 2007), the molecular mechanisms by which inflammatory
signals regulate stem and progenitor cell biology remain poorly
understood. The results presented here provide a clear mecha-
nism by which type 2 innate signals, such as IL-4/IL-13, regulate
the functions of the resident muscle progenitor cells, FAPs, to
facilitate muscle regeneration.
The functions performed by FAPs in injured muscles are
context dependent. In the experimental paradigm of CTX-
mediated muscle regeneration, factors synthesized by FAPs
support myogenic differentiation of MPs (Joe et al., 2010). In
contrast, in the experimental paradigm of glycerol-induced
muscle degeneration, FAPs contribute to adipogenic infiltration
of injured muscle, resulting in its fatty degeneration (Uezumi
et al., 2010). In both of these experimental models, cell-nonau-
tonomous signals control the ultimate fate adopted by FAPs in
injured muscle. In this context, our current work demonstrates
that injury leads to the formation of a dynamic niche that provides
signals to regulate the functionality of FAPs. Specifically, muscle
injury leads to the recruitment of eosinophils, which form the
transitional niche for the proliferating FAPs via secretion of IL-4
(Figure 7K). In the presence of IL-4, FAPs proliferate as fibro-
blasts to support myogenesis by facilitating the clearance of
necrotic debris. However, in its absence, FAPs fail to clear
necrotic muscle fibers and differentiate into adipocytes, contrib-
uting to the persistence of cellular debris and fatty degeneration
of skeletal muscle.
A surprising finding of our work was that IL-4/IL-13 signaling is
not required in macrophages to mediate muscle regeneration.
This result contrasts with previous reports that have suggested
an important role for macrophages—M2-type alternatively acti-
vated macrophages in particular—in muscle repair after injury
(Arnold et al., 2007; Ruffell et al., 2009). One of these studies
employed CD11b-DTR mice to acutely deplete monocytes and
macrophages after initiation of muscle injury. These authors
observed that early depletion of CD11b+ cells resulted in a
dramatic defect in muscle regeneration, whereas later depletion
of CD11b+ cells had only a modest effect on muscle’s regenera-
tive response (Arnold et al., 2007). Based on these findings, the
authors concluded that early depletion of circulating monocytes,
which give rise to recruited macrophages in injured muscles
(Gordon and Taylor, 2005), prevents muscle regeneration.
However, eosinophils, which share the myeloid developmental
lineage with monocytes and macrophages (Rothenberg and
Hogan, 2006), express both CD11b and F4/80 (encoded by
Emr1) (McGarry and Stewart, 1991; Wu et al., 2011). In light of
our genetic results with eosinophil-deficient DdblGATA mice,
an alternative interpretation of these previous results would be
that administration of diphtheria toxin to CD11b-DTR mice also386 Cell 153, 376–388, April 11, 2013 ª2013 Elsevier Inc.depletes eosinophils, which we now know are required for
myogenesis.
It is widely recognized that regeneration of injured tissues re-
quires clearance of cellular debris (Stoick-Cooper et al., 2007).
Previously, this function has been ascribed to macrophages,
which rapidly infiltrate injured muscle (Arnold et al., 2007; Tidball
and Villalta, 2010). Although persistence of necrotic debris was
observed in mice lacking type 2 cytokines IL-4 and IL-13, dele-
tion of its signaling receptor, IL-4Ra, in myeloid cells did not
significantly impair debris clearance or muscle regeneration.
These observations suggest the potential involvement of a non-
myeloid cell in the removal of damaged muscle fibers. Indeed,
multiple lines of evidence presented here demonstrate that
FAPs, which rapidly proliferate after injury, are critically impor-
tant for the clearance of injured muscle fibers. First, FAPs are
capable of rapidly phagocytizing necrotic cellular debris in vitro
and can outcompete macrophages (4:1) for engulfment of
necrotic debris in vivo. Second, the ability of FAPs to degrade
necrotic debris is reduced in animals lacking type 2 innate
signals. Third, deletion of Il-4ra in FAPs is sufficient to impair
the clearance of muscle debris, delaying muscle regeneration.
Fourth, administration of IL-4 to injured Il4/Il13/ mice, which
normally harbor necrotic debris, enhances the clearance of
necrotic muscle fibers. Taken together, these data broaden the
functions performed by FAPs during muscle’s regenera-
tive response to injury and demonstrate that type 2 cytokines
(IL-4 and IL-13) control nearly all known aspects of FAPs’
functionality.
A previous report by Horsley et al. (2003) had suggested that
regenerating myofibers secrete IL-4 to stimulate myoblast fusion
and muscle fiber growth. However, the results reported here
differ from those of Horsley et al. (2003) in a number of important
ways. First, using the highly sensitive and specific IL-4 reporter
line, the 4get mice, we failed to detect expression of IL-4 in
regenerating myofibers during the entire time course of muscle
regeneration. Instead, we found that eosinophils were the domi-
nant cell type competent for IL-4 secretion in regenerating
muscles. Second, our results with Il4raf/fPax7CreERT2mice, which
lack IL-4Ra in Pax7+ satellite cells, suggest that IL-4Ra signaling
in Pax7-derived myoblasts and myofibers is not essential for
regeneration ofmuscle after CTX injury. Rather, our data suggest
a dominant role for IL-4/IL-4Ra signaling in the regulation of
FAPs fate and actions in regenerating muscles.
From an evolutionary perspective, it is intriguing to speculate
why type 2 innate immune responses are integrally involved in
orchestrating tissue repair and regeneration. An insight into
this issue is provided by the interactions between the mamma-
lian host and helminth pathogens, the potent inducers of
type 2 immunity (Anthony et al., 2007; Maizels and Yazdan-
bakhsh, 2003). Because helminth infections are ubiquitous
(many vertebrate species are infected with tens to thousands
of worms in the wild), chronic (lasting months to years), and
tissue damaging (the migratory behavior of helminths causes
severe tissue damage in the host), it has been postulated that
antihelminth immunity might have been grafted onto the host’s
modules of tissue repair and remodeling (Allen and Wynn,
2011; Karp and Murray, 2012; Palm et al., 2012). Partial support
for this hypothesis is provided by studies demonstrating the
involvement of type 2 innate immunity in the repair of damaged
epithelial surfaces, such as skin, colon, or lung, via formation
of scar tissue (Chen et al., 2012; Loke et al., 2007; Lucas et al.,
2010; Seno et al., 2009). However, whether type 2 innate immune
responses actively orchestrate complete regeneration of tissues
is a question that previously had not been addressed. Our work
provides an example of how type 2 innate immune cells and their
signals instruct the behavior of resident stem cells, such as FAPs
in skeletal muscle, to orchestrate tissue regeneration. In aggre-
gate, these findings suggest that activation of type 2 innate
immunity confers tolerance to tissue damage by stimulating mul-
tiple cellular pathways of repair, ranging from the quick fix pro-
vided by scar formation to the complete regeneration of tissues
such as skeletal muscle. Finally, because venomous bites, toxin
ingestion, and helminth infections cause injury to a variety of host
tissues (Palm et al., 2012), it will be important to determine
whether type 2 innate immune responses are universally em-
ployed to promote tolerogenic disposal of necrotic debris,
thereby promoting the repair of damaged tissues. If so, it will
suggest that activation of type 2 innate immunity is a general
strategy employed by the host to defend tissues against damage
caused by environmental insults and pathogens (Medzhitov
et al., 2012; Palm et al., 2012).
EXPERIMENTAL PROCEDURES
Extended Experimental Procedures are included in the Supplemental
Information.
Animals
All animal coloniesweremaintained in theCVRI’s pathogen-free barrier facility,
and all experiments were performed in accordance with institutional guide-
lines. Male mice aged 8–16 weeks were used for the muscle regeneration
studies. The following strains of mice were used in these studies: Balb/cJ
(WT), DdblGATA, Il4/Il13/, 4get, 4get DdblGATA, Il4ra/, Stat6/, Il4raf/f,
and Il4raf/fLysMCre mice, all on the BALB/cJ background. YARG, Il4raf/f,
Il4raf/fPdgfraCre, Il4raf/fPax7CreERT2, and Pdgfra-GFP mice on C57Bl/6J back-
ground were also used in these studies. Muscle damagewas induced by injec-
tion of 50 ml of 20 mM cardiotoxin Naja nigricollis (Calbiochem) directly into the
midbelly of TA muscle. For the muscle degeneration model, 50 ml of 50% glyc-
erol solution in 13 HBSS was injected into the midbelly of TA muscle. The
contralateral side received PBS as vehicle control. IL-4 (2 mg, Peprotech) com-
plexed to anti-IL-4 antibody (4 mg, 11B11, UCSF) was intraperitoneally injected
on day 1 and 4 after initiation of muscle injury with glycerol. To assess muscle
damage, mice were given an intraperitoneal injection of Evans blue dye
(25 mg/kg) 24 hr prior to sacrifice. To induce Cre-mediated recombination,
Il4raf/fPax7CreERT2 mice were injected daily with tamoxifen (1.5 mg per 20 g
body weight) for 5 consecutive days. Mice were rested for 2 days prior to injec-
tion of CTX for muscle regeneration studies.
BrdU Labeling Studies
In vitro: FAPs were cultured in DMEM supplemented with 2% BSA for
24 hr in the presence or absence of IL-4 (10 nM). Cells were labeled with
BrdU (10 mM, Sigma) during the last 30 min of stimulation. In vivo: all BrdU
labeling studies were performed 1 day after injection of CTX into the TA
muscles. Mice were given an intraperitoneal injection of BrdU (100 mg/kg)
3 hr prior to sacrifice.
Statistical Analysis
All experiments were repeated at least two to three independent times, and the
data are presented as mean ± SEM. Statistical significance was determined
using the Student’s t test. A p value of < 0.05 was considered to be statistically
significant and is presented as *p < 0.05, **p < 0.01, or ***p < 0.001.ACCESSION NUMBERS
The GEO accession number for the microarray data reported in this paper is
GSE44933.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and five tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2013.02.053.
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